Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to 0.39%.

  • Avidity Biosciences' Return on Capital Employed fell 1600.0% to 0.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.38% for FY2024, which is 500.0% up from last year.
  • Avidity Biosciences' Return on Capital Employed amounted to 0.39% in Q3 2025, which was down 1600.0% from 0.41% recorded in Q2 2025.
  • Avidity Biosciences' Return on Capital Employed's 5-year high stood at 0.2% during Q1 2021, with a 5-year trough of 0.45% in Q4 2023.
  • Its 5-year average for Return on Capital Employed is 0.33%, with a median of 0.35% in 2023.
  • In the last 5 years, Avidity Biosciences' Return on Capital Employed tumbled by -1800bps in 2021 and then soared by 2000bps in 2024.
  • Over the past 5 years, Avidity Biosciences' Return on Capital Employed (Quarter) stood at 0.3% in 2021, then fell by -25bps to 0.37% in 2022, then decreased by -22bps to 0.45% in 2023, then soared by 44bps to 0.25% in 2024, then tumbled by -54bps to 0.39% in 2025.
  • Its last three reported values are 0.39% in Q3 2025, 0.41% for Q2 2025, and 0.3% during Q1 2025.